Predictive validity of the Scale of Prodromal Symptoms (SOPS)

Actas Espanolas de Psiquiatria

Volumn 34, Issue 4, 2006, Pages 216-223

  Lemos, Serafin ^a   Vallina, O ^b   Fernandez P ^a   Ortega, J A ^b   Garcia P ^b   Gutierrez A ^b   Garcia A ^b   Bobes, J ^a   Miller, T ^c  

^a UNIVERSITY OF OVIEDO   (Spain)

^b Servicio Cantabro de Salud   (Spain)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Early detection; Prevention; Prodromic signs; Psychoses

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; FEMALE; HUMAN; MALE; PREDICTION AND FORECASTING; PSYCHOLOGICAL ASPECT; PSYCHOSIS; QUESTIONNAIRE; REPRODUCIBILITY; VALIDATION STUDY;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PSYCHOTIC DISORDERS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 33746904372     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. McGlashan TH, Miller TJ, Woods SW. Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk. Schizophr Bull 2001;27:563-70.
2. McGorry PD, Henry L, Maude D, Phillips L. Intervenciones psicológicas con orientación preventiva en los inicios de la psicosis. In: Perris C, McGorry PD, editors. Psicoterapia cognitiva para los trastornos psicóticos y de personalidad: manual teorico-práctico. Bilbao: Desclée de Brouwer (Orig. 1998), 2004; p. 263-88.
3. McGorry PD, Phillips LJ, Yung AR. Recognition and treatment of the pre-psychotic phase of psychotic disorders: frontier of fantasy? En: Miller TJ, Mednick SA, McGlashan TH, Libiger J, Johannessen JO, editors. Early intervention in psychotic disorders. Dordrecht: Kluwer Academic, 2001; p. 101-22.
4. Johannenssen J, Larsen T, McGlashan T, Vaglum P. Early intervention in psychosis: the TIPS-project, a multi-centre study in Scandinavia. En: Martindale B, Bateman A, Crowe M, Margison F, editores. Psychosis: psychological approaches and their effectiveness. London: Gaskell, 2000; p. 210-34.
5. Edwards J, McGorry PD. Intervención precoz en los trastornos psicóticos: una aproximación critica en la prevención de la morbidez psicológica. In: Perris C, McGorry PD, editors. Psicoterapia cognitiva para los trastornos psicóticos y de personalidad: manual teórico-práctico. Bilbao: Desclée de Brouwer (Orig. 1998), 2004; p. 211-43.
6. Edwards J, McGorry PD. Implementing early intervention in psychosis: a guide to establishing early psychosis services. Philadelphia: Martin Dunitz, 2002.
7. Birchwood M, Spencer E, McGovern D. Schizophrenia: early warning signs. Adv Psychiat Treat 2000;6:93-101.
8. Birchwood M, Jackson C, Fowler D, editors. Early intervention in psychosis: a guide to concepts, evidence and interventions. Chichester: Wiley, 2000.
9. Miller TJ, McGlashan TH. The risks of not intervening in pre-onset psychotic illness. J Ment Health 2003;12:345-9.
10. Miller PM, Byrne M, Hodges A, Lawrie SM, Johnstone EC. Childhood behaviour, psychotic symptoms and psychosis onset in young people at high risk of schizophrenia: early findings from the Edinburgh High Risk Study. Psychol Med 2002;32: 173-9.
11. Cornblatt B, Lencz T, Smith S, Auther A. Treatment of schizophrenia prodrome. En: Stone WS, Faraone SV, Tsuang MT, editores. Early clinical intervention and prevention in schizophrenia. Totowa: Humana Press, 2004; p. 303-23.
12. McGorry PD, Krstev H, Harrigan S. Early detection and treatment delay: implications for outcome in early detection. Curr Opin Psychiatry 2000;13:37-43.
13. McGlashan TH. Early detection and intervention of schizophrenia: rationale and research. Br J Psychiat 1998;172(Suppl. 33):3-6.
14. McGorry P. Preventive strategies in early psychosis: verging on reality. Br J Psychiatry 1998;172(Suppl. 33):1-2.
15. McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller TJ, Woods SW, et al. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: I. Study rational and design. Schizophr Res 2003;61:7-18.
16. Miller TJ, Zipursky RB, Perkins DO, Addington J, Woods SW, Hawkins KA, et al. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: II. Baseline characteristics of the «prodromal» sample. Schizophr Res 2003;61:19-30.
17. Yung AR, Phillips U, McGorry PD, McFarlane CA, Francey S, Harrigan S, et al. Prediction of psychosis: A step towards indicated prevention of schizophrenia. Br J Psychiatry 1998;172(Suppl. 33): 14-20.
18. McGlashan TH, Miller TJ, Woods SW. A scale for the assessment of prodromal symptoms and states. In: Miller TJ, Mednick SA, McGlashan TH, Libiger J, Johannessen JO, editores. Early intervention in psychotic disorders. Dordrecht, The Netherlands: Kluwer Academic, 2001; p. 135-9.
19. Miller TJ, McGlashan TH, Rosen JL, Somjee L, Markovich PJ, Stein K, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: Preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry 2002;159:863-5.
20. Miller TJ, McGlashan TH, Woods SW, Stein K, Driesen N, Corcoran CM, et al. Symptom assessment in schizophrenic prodromal states. Psychiat Quaterl 1999;70:273-87.
21. th ed. Washington: American Psychiatric Association, 1994.
22. Andreasen NC, Endicott J, Spitzer RL, Winokur G. The family history method using diagnostic criteria: reliability and validity. Arch Gen Psychiatry 1977;34:1229-35.
23. Hall R. Global assessment of functioning: a modified scale. Psychosomatics 1995;36:267-5.
24. Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Ventura J, McFarlane W, et al. Prodromal assessment with the Structured Interview for Prodromal Symptoms and the Scale of Prodromal Symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 2003;29:703-15.
25. Hawkins KA, McGlashan TH, Quinlan D, Miller TJ, Perkins DO, Zipursky RB, et al. Factorial structure of the scale of prodromal symptoms. Schizophr Res 2004;68:339-47.
26. Häfner H, van der Heiden W. Epidemiology of schizophrenia. Can J Psychiatry 1997;42:139-51.
27. Yung AR, McGorry PD, McFarlane CA. Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull 1996;22:283-303.
28. Venables PH, Bailes K. The structure of schizotypy, its relation to subdiagnoses of schizophrenia and to sex and age. Br J Clin Psychol 1994;33:277-94.
29. Venables PH, Rector NA. The content and structure of schizotypy: a study using confirmatory factor analysis. Schizophr Bull 2000;26:587-602.
30. Häfner H, Maurer K, Löffler W, Fätkenheuer B, An der Heiden W, Riecher-Rössler A, et al. The epidemiology of early schizophrenia: influence of age and gender on onset. Br J Psychiatry 1994;164(Suppl. 23):29-38.
31. Lencz T, Smith CW, Auther A, Correll CU, Cornblait B. Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophr Res 2004;68:37-48.
32. McNeil TF, Cantor-Graae E. Neuromotor markers of risk for schizophrenia. Aus N Z J Psychiatry 2000;34(Suppl.):S86-90.